Authors
Loading...
Comparative laboratory analysis demonstrates structural and functional equivalence between biosynthetic and pancreatic human insulin, highlighting recombinant technology as a viable source.
Chance et al. (1981) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: